The treatment of hypertension and dyslipidemia in diabetes mellitus

被引：8
作者：
Fineberg, SE [1 ]
机构：
[1] Indiana Univ, Sch Med, Dept Med, Div Endocrinol & Metab, Indianapolis, IN 46202 USA
来源：
PRIMARY CARE | 1999年 / 26卷 / 04期
关键词：
D O I：
10.1016/S0095-4543(05)70141-X
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
The relationship between macrovascular complications of diabetes mellitus, hypertension, and dyslipidemia is explored. Management strategies for patients with lipid abnormalities are given, along with indications and use of available drug classes. Pharmacologic and nonpharmacologic approaches to hypertension management are reviewed. The controversies concerning the use of various classes of anti-hypertensive drugs including calcium channel blockers and diuretic therapy are also discussed.
引用
收藏
页码：951 / +
页数：15
相关论文
共 42 条
[1]   Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients [J].
Alderman, MH ;
Cohen, H ;
Roque, R ;
Madhavan, S .
LANCET, 1997, 349 (9052) :594-598
[2]  
*AM DIAB ASS, 1999, DIABETES CARE, V22, P532
[3]  
[Anonymous], 1991, JAMA, V265, P3255
[4]  
[Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI [10.1001/archinte.1997.00440420033005, DOI 10.1001/ARCHINTE.1997.00440420033005]
[5]   DIET, LIPOPROTEINS, AND THE PROGRESSION OF CORONARY ATHEROSCLEROSIS - THE LEIDEN INTERVENTION TRIAL [J].
ARNTZENIUS, AC ;
KROMHOUT, D ;
BARTH, JD ;
REIBER, JHC ;
BRUSCHKE, AVG ;
BUIS, B ;
VANGENT, CM ;
KEMPENVOOGD, N ;
STRIKWERDA, S ;
VANDERVELDE, EA .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (13) :805-811
[6]   Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men [J].
Assmann, G ;
Schulte, H ;
vonEckardstein, A .
AMERICAN JOURNAL OF CARDIOLOGY, 1996, 77 (14) :1179-1184
[7]   Hypertriglyceridemia as a cardiovascular risk factor [J].
Austin, MA ;
Hokanson, JE ;
Edwards, KL .
AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (4A) :7B-12B
[8]   EFFECTS OF ANTIHYPERTENSIVE TREATMENT ON INSULIN SENSITIVITY WITH SPECIAL REFERENCE TO ACE INHIBITORS [J].
BERNE, C ;
POLLARE, T ;
LITHELL, H .
DIABETES CARE, 1991, 14 :39-47
[9]   RELATION BETWEEN DOSE OF BENDROFLUAZIDE, ANTIHYPERTENSIVE EFFECT, AND ADVERSE BIOCHEMICAL EFFECTS [J].
CARLSEN, JE ;
KOBER, L ;
TORPPEDERSEN, C ;
JOHANSEN, P .
BRITISH MEDICAL JOURNAL, 1990, 300 (6730) :975-978
[10]   HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials data [J].
Crouse, JR ;
Byington, RP ;
Furberg, CD .
ATHEROSCLEROSIS, 1998, 138 (01) :11-24
12345